T1	p 118 136	pathologies of the
T2	p 353 380	98 patients aged between 18
T3	p 385 432	75 suffering from pain-inflammatory pathologies
T4	i 59 69	nimesulide
T5	i 73 84	suppository
T6	i 204 218	pharmaceutical
T7	i 266 278	. Nimesulide
T8	i 335 347	flurbiprofen
T9	i 488 503	one suppository
T10	o 30 38	efficacy
T11	o 46 55	tolerance
T12	o 148 162	, and throat ]
T13	o 169 194	efficacy and tolerability
T14	o 536 597	marked anti-inflammatory , analgesic and antipyretic activity
T15	o 627 650	progressive improvement
T16	o 682 694	inflammatory
T17	o 722 744	remission . Nimesulide
T18	o 755 803	greater speed and duration of therapeutic action
T19	o 824 854	effectiveness and tolerability